Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Christian Herzog, Koen Van Herck & Pierre Van Damme. (2021) Hepatitis A vaccination and its immunological and epidemiological long-term effects – a review of the evidence. Human Vaccines & Immunotherapeutics 17:5, pages 1496-1519.
Read now
Read now
Li Zhang. (2020) Hepatitis A vaccination. Human Vaccines & Immunotherapeutics 16:7, pages 1565-1573.
Read now
Read now
Ignasi Parrón, Caritat Planas, Pere Godoy, Sandra Manzanares-Laya, Ana Martínez, Maria Rosa Sala, Sofia Minguell, Nuria Torner, Mireia Jané & Angela Domínguez. (2017) Effectiveness of hepatitis A vaccination as post-exposure prophylaxis. Human Vaccines & Immunotherapeutics 13:2, pages 423-427.
Read now
Read now
Desmond Curran, Marc de Ridder & Thierry Van Effelterre. (2016) The impact of assumptions regarding vaccine-induced immunity on the public health and cost-effectiveness of hepatitis A vaccination: Is one dose sufficient?. Human Vaccines & Immunotherapeutics 12:11, pages 2765-2771.
Read now
Read now
Articles from other publishers (8)
Sai Krishna Susarla, Madhu Gupta, Kheya Ghosh Uttam, Sonali Palkar, Ashish Ramachandra Dhongade, K. Siva Ram Prasad, Vasudev Rajapantula, M.D. Ravi, N. Pradeep, M. Satish, B.C. Rajashakar, G. Sandhya, L. Rajendra, Devi Prasad Sahoo & Anand Kumar Kanakasapapathy. (2023) Immunogenicity and safety of HavisureTM vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study. Vaccine.
Crossref
Crossref
Nick M. Walsh, Heidi M. Soeters, Noele P. Nelson, Yury Khudyakov & Mark K. Weng. 2023. Plotkin's Vaccines. Plotkin's Vaccines
365
388.e15
.
Sai Krishna Susarla, Sonali Palkar, Pardha Saradhi SV, Arundhati Diwan, Supriya Barsode, M. Satish, BC Rajashakar, G. Sandhya, Rajendra Lingala & Devi Prasad Sahoo. (2021) Safety and immunogenicity of inactivated hepatitis-A vaccine developed by Human Biologicals Institute in two age groups of healthy subjects: A phase I open label study. Vaccine 39:15, pages 2088-2093.
Crossref
Crossref
Noele P. Nelson, Mark K. Weng, Megan G. Hofmeister, Kelly L. Moore, Mona Doshani, Saleem Kamili, Alaya Koneru, Penina Haber, Liesl Hagan, José R. Romero, Sarah Schillie & Aaron M. Harris. (2020) Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR. Recommendations and Reports 69:5, pages 1-38.
Crossref
Crossref
Joseph Torresi, Sarah McGuinness, Karin Leder, Daniel O’Brien, Tilman Ruff, Mike Starr & Katherine GibneyJoseph Torresi, Sarah McGuinness, Karin Leder, Daniel O’Brien, Tilman Ruff, Mike Starr & Katherine Gibney. 2019. Manual of Travel Medicine. Manual of Travel Medicine
297
376
.
Ruth Link-Gelles, Megan G. Hofmeister & Noele P. Nelson. (2018) Use of hepatitis A vaccine for post-exposure prophylaxis in individuals over 40 years of age: A systematic review of published studies and recommendations for vaccine use. Vaccine 36:20, pages 2745-2750.
Crossref
Crossref
A D Bushmanova, A A Sukhoruk, N V Ivanova & E V Esaulenko. (2017) Characteristics of hepatitis A on the background of chronic hepatitis B. Kazan medical journal 98:4, pages 521-526.
Crossref
Crossref
Jakob P. Cramer, Katrin Dubischar, Susanne Eder, Gerd D. Burchard, Tomas Jelinek, Bernd Jilma, Herwig Kollaritsch, Emil Reisinger & Kerstin Westritschnig. (2016) Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study. Vaccine 34:38, pages 4579-4585.
Crossref
Crossref